We are 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one CAS: 503615-03-0 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
Molecular Weight: 303.31300
Physical and Chemical Properties:
Boiling point:506.5±50.0 °C at 760 mmHg
Melting point: /
Flash point: 260.1±30.1 °C
Refractive index: 1.625
Appearance: Yellow powder
LC/MS:Conformity with the structure
NMR:Conformity with the structure
25kg cardboard drum or according to customer specified requirements
Storage:Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Application:Intermediates of Apixaban CAS:503612-47-3
Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.4635-59-0 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”6980-08-1 Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.2-(Chloromethyl)-1-fluoro-4-(trifluoromethyl)benzene Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.